Lilly Stock Soars, Increasing Profile of City’s Life Sciences District
Over a decade ago, Eli Lilly and Co. was struggling.
Read MoreTag Archives: Johnson & Johnson
J&J Announces Plan To Spin Off Consumer Health Division
Johnson & Johnson announced Friday, Nov. 12, that it will spin off its consumer health products so it can focus more on pharmaceuticals and medical devices.
Read MoreJohnson & Johnson Mandating Vaccines For Entire Workforce
Johnson & Johnson, the parent company of Warsaw-based DePuy Synthes, will soon require all employees and on-site contractors to be vaccinated against COVID-19.
Read More
Vaccination Clinic Next Week Will Offer Single Shot J&J Option
Another chance to get the COVID-19 vaccine returns next week in Warsaw.
Read More
OrthoWorx Working With DePuy-Synthes On Education Program
A Johnson & Johnson program to help prepare high school students for rewarding careers is coming to the Warsaw community.
Read More
Warsaw Clinic Relying On J&J Vaccine Cancelled; Five-Day Event Unaffected
A clinic planned for this Saturday in Warsaw was quickly cancelled after the federal government called for a pause on the use of Johnson & Johnson’s COVID-19 vaccine.
Read MoreGovernment Agencies Call For ‘Pause” In Use Of J&J Vaccine
The Food and Drug Administration and the Centers for Disease Control and Prevention on Tuesday, April 13, officially recommended a pause in the use of the Johnson & Johnson COVID-19 vaccine “out of an abundance of caution.”
Read More
DePuy Synthes Confirms Plans To Move Distribution Center
WARSAW – A spokesperson for DePuy Sythes confirmed some jobs will be moved from Warsaw in about two years when its distribution center is moved to central Indiana. Mindy Tinsley, a spokesperson for the company, declined to say how many jobs it would involve and said it’s part … Read More
Hill Announces $116.9 Million Settlement With Johnson & Johnson
INDIANAPOLIS — Attorney General Curtis Hill today announced a settlement involving 41 states and the District of Columbia requiring Johnson & Johnson and its subsidiary Ethicon Inc. to pay nearly $116.9 million for their deceptive marketing of transvaginal surgical mesh devices. A multistate investigation found the companies violated … Read More
Wrongful Death Suits Begin Over Synthes-Made Bone Cement
WASHINGTON — A series of civil lawsuits has commenced against DePuy Synthes in the deaths of five spinal patients. MassDevice reports the lawsuits center on Norian XR bone cement, known to cause clots in the bloodstream. The cement was used in at least five spinal surgeries and all … Read More
DePuy Synthes Execs Grow OrthoWorx Board
By KYLIE VELETA Special Projects Reporter, Inside Indiana Business WARSAW — Two executives from DePuy Synthes Companies are joining the board of directors of OrthoWorx, the state’s orthopedic initiative. Vice President of Worldwide Clinical Research Paul Voorhorst and Plant Manager Ray Gonzalez are replacing a board member who is stepping … Read More
MedStar Ordered To Provide Info On DePuy Hip Transplants
WARSAW — Texas-based surgical funding company MedStar has been court-ordered to turn over information pertaining to DePuy-manufactured artificial hips. According to a Reuters report, Johnson & Johnson-owned DePuy requested the order in light of lawsuits filed by surgery patients who received the artificial hips. In response, U.S. District Judge, … Read More
J&J, Medtronic Settle Lawsuit
Johnson & Johnson (NYSE:JNJ) and Medtronic (NYSE:MDT) agreed to a confidential settlement of a lawsuit brought by Medtronic MiniMed accusing J&J’s Animas diabetes business of infringing patents, according to a regulatory filing. MiniMed sued Animas in May 2012, alleging that the Animas OneTouch Ping glucose management system and the IR 1250, … Read More
Lawyers Were Winners In DePuy Lawsuits
When Johnson & Johnson (NYSE:JNJ) agreed to a $2.5 billion settlement to close some 8,000 cases over its metal-on-metal hip implants, about 1/3 of that money went to the lawyers and legal teams representing the cases. Lawyers took an average of $90,000 of each patient’s $250,000 award, according … Read More
J&J Fined $17 Million From Medicaid Fraud
In its largest-ever settlement of a Medicaid fraud case, the state of Indiana will receive nearly $17 million from Johnson & Johnson and its subsidiaries to resolve lawsuits alleging the pharmaceutical manufacturer engaged in illegal off-label marketing and payment of kickbacks to promote its drugs Risperdal and Invega, … Read More
Hip Implants Costing J&J $3 Billion
According to a recent report, Johnson & Johnson, the world’s largest seller of health-care products, has discussed paying more than $3 billion to settle lawsuits over its recalled hip implants. J&J’s Warsaw-based DePuy unit recalled 93,000 implants in 2010 – including 37,000 in the U.S. – after more … Read More